1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32008
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVillani, Flavio-
dc.contributor.authorCianci, Vittoria-
dc.contributor.authorDi Bonaventura, Carlo-
dc.contributor.authorDi Gennaro, Giancarlo-
dc.contributor.authorGalimberti, Carlo Andrea-
dc.contributor.authorGuerrini, Renzo-
dc.contributor.authorLa Neve, Angela-
dc.contributor.authorMecarelli, Oriano-
dc.contributor.authorPietrafusa, Nicola-
dc.contributor.authorSpecchio, Nicola-
dc.contributor.authorVigevano, Federico-
dc.contributor.authorPerucca, Emilio-
dc.date2023-
dc.date.accessioned2023-01-24T03:20:02Z-
dc.date.available2023-01-24T03:20:02Z-
dc.date.issued2023-01-20-
dc.identifier.citationExpert Review of Neurotherapeutics 2023en_US
dc.identifier.issn1744-8360-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32008-
dc.description.abstractCenobamate is a new antiseizure medication (ASM) recently introduced in the USA for the treatment of adults with focal-onset seizures. In March 2021, the European Commission authorized its use for the adjunctive treatment of focal-onset seizures with or without secondary generalization (focal seizures with or without progression to bilateral tonic-clonic seizures, according to current ILAE terminology) in adults with epilepsy not adequately controlled despite the treatment with at least two ASMs.en_US
dc.language.isoeng-
dc.subjectCenobamateen_US
dc.subjectdrug resistanceen_US
dc.subjectepilepsyen_US
dc.subjectfocal seizuresen_US
dc.titleUse of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleExpert Review of Neurotherapeuticsen_US
dc.identifier.affiliationDivision of Clinical Neurophysiology and Epilepsy Center, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.en_US
dc.identifier.affiliationRegional Epilepsy Centre, Great Metropolitan Hospital, Bianchi-Melacrino Morelli, Reggio, Italy.en_US
dc.identifier.affiliationEpilepsy Centre, Department of Human Neurosciences, "Sapienza" University of Rome, Rome, Italy.en_US
dc.identifier.affiliationNEUROMED, IRCCS, Pozzilli, Isernia, Italy.en_US
dc.identifier.affiliationEpilepsy Center, Mondino Foundation, IRCCS, Pavia, Italy.en_US
dc.identifier.affiliationNeuroscience Department, Children's Hospital A. Meyer-University of Florence, Italy.en_US
dc.identifier.affiliationDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University Hospital of Bari "A. Moro", Bari, Italy.en_US
dc.identifier.affiliationDepartment of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.en_US
dc.identifier.affiliationDepartment of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.en_US
dc.identifier.affiliationDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy, Department of Medicine (Austin Health), University of Melbourne, and Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.doi10.1080/14737175.2023.2171291en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-7272-7079en_US
dc.identifier.pubmedid36662573-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Feb 16, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.